A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors
Clinical trial NCT06188208 · TERMINATED
Trial details
- NCT number
- NCT06188208
- Sponsor
- Vividion Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-05
- Primary completion
- 2026-02-20
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.